Epstein-Barr virus latent infection in vivo

Reviews in Medical Virology

Volumn 7, Issue 2, 1997, Pages 97-106

  Steven, Neil M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ACTIVATION; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HOST RESISTANCE; HUMAN; INFECTION RISK; INFECTIOUS MONONUCLEOSIS; LATENT VIRUS INFECTION; REVIEW;

EID: 0030797562     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199707)7:2<97::AID-RMV190>3.0.CO;2-M     Document Type: Review

References (12)

1. University Health Physicians, PHLS Laboratories (1971) Infectious mononucleosis and its relationship to EB virus antibody. Br. Med. J. 4, 643-646.
2. Niedobitek, G. and Young, L. S. (1994). Epstein-Barr virus persistence and virus associated tumours. Lancet 343, 333-335.
3. Nemerow, G. R., Wolfert, R., McNaughton, M. and Cooper, N. R. (1985). Identification and characterisation of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55, 347-351.
4. Hurley, E. A. and Thorley-Lawson, D. A. (1988). B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168, 2059-2075.
5. Rickinson, A. and Kieff, E. Epstein-Barr virus. In, Fields Virology, ed. by B. N. Fields, P. M. Howley et al., vol. 2, pp. 2397-2446. Lippincott-Raven, Philadelphia.
6. Yoshiyama, H., Shimizu, N. and Tekada, K. (1995). Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus infection. EMBO J. 14 (15), 3706-3711.
7. Meijer, C., Jiwa, N., Dukers, D. et al. (1996). Epstein-Barr virus and human T-cell lymphomas. Semin. Cancer Biol. 7, 191-196.
8. Brooks, L., Yao, Q. Y., Rickinson, A. B. and Young, L. S. (1992). Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66, 2689-2697.
9. Sample, J., Brooks, L., Sample, C. et al. (1991). Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Nat. Acad. Sci. USA 88, 6343-6347.
10. Kerr, B. M., Lear, A. L., Rowe, M. et al. (1992). Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promotor usage. Virology 187, 189-201.
11. Rowe, M., Lear, A. L., Croom-Carter, D., Davies, A. H. and Rickinson, A. B. (1992). Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 66, 122-131.
12. Chen, C-L., Sadler, R. H., Walling, D. M., Su, I-J., Hsieh, H-C. and Raab-Traub, N. (1993). Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J. Virol. 67, 6303-6308.